Dental Methods in the Medical Treatment of Tension Headache

ABSTRACT

The tension headache is a common recurring affliction in the population with prevalence of 12%. Purpose is to vindicate the medico-dental approach in treatment of tension headache. Each of the 120patients for this study underwent a screening process for the patognostic symptoms that lead to diagnosing tension headache: strong temporal pulsating pain, nausea, photophobia, phonophobia, parastesia and/or light flashing hallucinations. The patients were divided into 2separate groups. The 1group of 60patients were treated with pharmaceuticals almotriptan 15mg/day and ibuprofen 800mg/day. The 2group in addition to the prescribed pharmaceuticals was given dental splints and myofascial exercises. The check-ups for both groups were after 2,6 and 12months. Each patient was assigned to keep a journal of the pain episodes and pain level on a scale from 1 to 10. The average episode frequency for the 1group of patients on each check-up was 3,78episodes/monthly(2months), 3,24episodes/monthly(6months) and 0,78episodes/monthly(12months) and pain level 8,7(2months); 7,9(6months); 2,1(12months) respectively. For the 2group the average episode frequency for each check-up was 3,34episodes/monthly(2months), 2, 68episodes/monthly(6months), 0,34episodes/monthly(12months) and pain level 8,6(2months); 5,4(6months); 0,5(12months) respectively. Medico-pharmaceutical treatment of the  tension headache although substantially efficient could be improved in quality and reduced in duration by simultaneous dental treatment with dental splints and myofascial exercises. 

Keywords: Migrane headache, Dental splints, Myofascial exercises, Medical treatment, Dental Treatment.

REFERENCES

1. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987;31:199-209.
2. Obermann M, Mueller D, Yoon M-S, Pageler L, Diener, HC, Katsarava, Z.  tension headache with isolated facial pain: a diagnostic challenge. Cephalalgia 2007:27;1278-1282.
3. Zakrzewska JM, Harrison SD. Assessment and Management of Orofacial Pain. Pain Research  and Clinical Management, Vol 14. Chapter 14: 255 – 266.
4. Orofacial Pain: Guidelines for assessment, Diagnosis and Management. 3rd Ed. Jeffrey Okeson Quintessence 1996
5. Agerberg G, Carlsson GE. Functional disorders of the masticatory system. ActaOdontScand 1972; 32: 597 – 613
6. Agerberg G, Bergenholz A. Craniomandibular disorders in adult populations of West Bothnia, Sweden. ActoOdontolScand 1989;47: 129 -140.
7. Mense S, Simons D. Russell JI. Muscle Pain Understandingits nature, diagnosis and treatment. Lippincott Williams and Wilkins 2001; Ch. 1: 7 – 15.
8. Stuginski-Barbosa J, Macedo HR, Bigal ME, Speciali JG. Signs of temporomandibular disorders in  tension headache patients: A prospective, controlled study. Clin J Pain 2010;26:418–421.
9. Nilsson IM. Reliability, validity, incidence and impact of temporormandibular pain disorders in adolescents. Swed Dent J Suppl 2007;7–86. 87
10. Haley D, Schiffman E, Baker C, Belgrade M. The comparison  of patients suffering from temporomandibular disorders and a general headache population. Headache 1993;33:210 213. 88
11. Schokker RP, Hansson TL, Ansink BJ. Craniomandibular  disorders in patients with different types of headache. J CraniomandibDisord 1990;4:47–51. 89
12. Glaros AG, Urban D, Locke J. Headache and temporomandibular disorders: Evidence for diagnostic and behavioural overlap. Cephalalgia 2007;27:542–549.90
13. Ciancaglini R, Radaelli G. The relationship between headache  and symptoms of temporomandibular disorder in the general population. J Dent 2001;29:93–98.
14. Svensson P. Muscle pain in the head: Overlap between temporomandibular disorders and tension-type headaches. CurrOpinNeurol 2007;20:320–325.92
15. Jensen R, Olesen J. Initiating mechanisms of experimentally induced tension-type headache. Cephalalgia 1996;16:175–182. 93
16. Jensen R. Pathophysiological mechanisms of tension-type headache: A review of  epidemiological and experimental studies. Cephalalgia 1999;19:602–621.94
17. Lim PF, Smith S, Bhalang K, Slade GD, Maixner W.  Development of temporomandibular disorders is associated with greater bodily pain experience. Clin J Pain 2010;26:116–120. 95
18. Marklund S, Wiesinger B, Wanman A. Reciprocal influence on the incidence of symptoms in trigeminally and spinally innervated areas. Eur J Pain 2010;14:366–371.
19. Bergstrom I, List T, Magnusson T. A follow-up study of subjective symptoms of temporomandibular disorders in patients who received acupuncture and/or interocclusal appliance therapy 18–20 years earlier. ActaOdontolScand 2008;66:88–92.
20. Ekberg E, Vallon D, Nilner M. Treatment outcome of headache after occlusal appliance therapy in a randomised controlled trial among patients with temporomandibular disorders of mainly arthrogenous origin. Swed Dent J 2002;26:115–124.
21. Ekberg EC, Nilner M. Treatment outcome of short- and long-term appliance therapy in patients with TMD of myogenous origin and tension-type headache. J Oral Rehabil 2006;33:713–721
22. Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic  tension headache and episodic  tension headache. J Occup Environ Med 2010;52:8–14. 100.
23. Holroyd KA, Stensland M, Lipchik GL, Hill KR, O’Donnell FS, Cordingley G. Psychosocial correlates and impact of chronic tension-type headaches. Headache 2000;40:3–16.
24. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: A Danish population study. J Epidemiol Community Health 1992;46:443–446.
25. Anderson GC, John MT, Ohrbach R, et al. Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain 2010;152:765–771.
26. Kalaykova S, Naeije M, Huddleston Slater JJ, Lobbezoo F. Is condylar position a predictor for functional signs of TMJ hypermobility? J Oral Rehabil 2006;33:349–355.
27. Okeson JP. Critical commentary 1: Evaluation of the research diagnostic criteria for temporomandibular disorders for the recognition of an anterior disc displacement with reduction. J Orofac Pain 2009;23:312–315.
28. Ahmad M, Hollender L, Anderson Q, et al. Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD): Development of image analysis criteria and examiner reliability for image analysis. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2009;107:844–860.
29. American Association of Oral and Maxillofacial Surgeons. Parameters of Care: Clinical Practice Guidelines for Oral and Maxillofacial Surgery (AAOMS ParCare 2012). J Oral MaxillofacSurg 2012;70(suppl 3):e204–e231.
30. Nicholas MK, Linton SJ, Watson PJ, Main CJ. “Decade of the Flags” Working Group. Early identification and management of psychological risk factors (“yellow flags”) in patients with low back pain: A reappraisal. PhysTher 2011;91:737–753.
31. Galli U, Ettlin DA, Palla S, Ehlert U, Gaab J. Do illness perceptions predict pain-related disability and mood in chronic orofacial pain patients? A 6-month follow-up study. Eur J Pain 2010;14:550–558.
32. Wright AR, Gatchel RJ, Wildenstein L, Riggs R, Buschang P, Ellis E 3rd. Biopsychosocial differences between high-risk and low-risk patients with acute TMD-related pain. J Am Dent Assoc 2004;135:474–483.
33. Litt MD, Shafer DM, Kreutzer DL. Brief cognitive-behavioral  treatment for TMD pain: Long-term outcomes and moderators of treatment. Pain 2010;151:110–116.
34. Ohrbach R, Fillingim RB, Mulkey F, et al. Clinical findings and pain symptoms as potential risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12:T27–T45.
35. Ohrbach R, Bair E, Fillingim RB, et al. Clinical orofacial characteristics associated with risk of first-onset TMD: The OPPERA prospective cohort study. J Pain 2013;14(suppl 2):T33–T50.
36. Tania Luthra, Rahul Agarwal, Mamidala Estari, Uma Adepally, Subhabrata Sen. A novel
    library of -arylketones as potential inhibitors of α-glucosidase: Their design, synthesis, in
    vitro and in vivo studies. Nature-Scientific Reports, 2017, 7(1), 1-13. DOI: 10.1038/s41598-
    017-13798-y.
37. Fillingim RB, Ohrbach R, Greenspan JD, et al.Psychological factors associated with development of TMD: The OPPERA prospective cohort study. J Pain 2013;14(suppl 2):T75–T90.
38. Rugh JD, Ohrbach R. Occlusalparafunction. In: Mohl ND, Zarb GA, Carlsson GE,
39. Rugh JD (eds). A Textbook of Occlusion. Chicago: Quintessence, 1988:249–261.
40. Peck CC, Goulet JP, Lobbezoo F, et al. Expanding the taxonomy of the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). J Oral Rehabil 2014;41:2–23.
41. Garofalo JP, Wesley AL. Research Diagnostic Criteria for Temporomandibular Disorders: Reflection of the physicalpsychological interface. APS Bulletin 1997;May/June:4–16.
42. Gonzalez YM, Schiffman EL, Gordon SM, et al. Development of a brief and effective TMD-pain screening questionnaire: Reliability and validity. J Am Dent Assoc 2011;24:1183–1191.
43. Schiffman E, Ohrbach R, List T, et al. Diagnostic criteria for headache attributed to temporomandibular disorders. Cephalalgia 2012;32:683–692.
44. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, ed 3 (beta version). Cephalalgia 2013;33:629–808.
45. Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics 2009;50:613–621.
46. Ohrbach R, Larsson P, List T. The jaw functional limitation scale: Development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain 2008;22:219–230.
47. Ohrbach R, Granger C, List T, Dworkin S. Preliminary development and validation of the Jaw Functional Limitation Scale. Community Dent Oral Epidemiol 2008;36:228–236.
48. Markiewicz MR, Ohrbach R, McCall WD Jr. Oral behaviors checklist: Reliability of performance in targeted waking-state behaviors. J Orofac Pain 2006;20:306–316.
49. Lowe B, Decker O, Muller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008;46:266–274.
50. Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psychosocial risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12:T46–T60.
51. Greene CS. Validity of the Research Diagnostic Criteria for Temporomandibular Disorders Axis I in clinical and research settings. J Orofac Pain 2009;23:20–23.